Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-03 00:01 | 2022-08-01 | N/A | Blackstone Real Estate Income Trust, Inc. | Agarwal A.J. | Director, Officer - President | Real Estate Investment Trusts | BUY | $14.98 | 333,716 | $5,000,000 | 607,413 | +121.9% |
| 2022-08-03 00:00 | 2022-08-01 | N/A | Blackstone Real Estate Income Trust, Inc. | LePatner Wesley | Director, Officer - Chief Operating Officer | Real Estate Investment Trusts | BUY | $14.98 | 166,858 | $2,500,000 | 193,453 | +627.4% |
| 2022-08-03 00:00 | 2022-08-01 | N/A | Blackstone Real Estate Income Trust, Inc. | Harper Robert G IV | Officer - Head of Asset Management | Real Estate Investment Trusts | BUY | $14.98 | 200,230 | $3,000,000 | 392,958 | +103.9% |
| 2022-08-03 00:01 | 2022-08-01 | N/A | Blackstone Real Estate Income Trust, Inc. | Cohen Frank | Director, Officer - Chief Executive Officer | Real Estate Investment Trusts | BUY | $14.98 | 667,432 | $10,000,000 | 200,230 | +100.0% |
| 2022-08-03 00:00 | 2022-08-01 | N/A | Blackstone Real Estate Income Trust, Inc. | Kim Brian | Director, Officer - See Remarks | Real Estate Investment Trusts | BUY | $14.98 | 233,601 | $3,500,000 | 283,452 | +468.6% |
| 2022-08-03 03:32 | 2022-08-01 | GWRS | Global Water Resources, Inc. | Cohn Andrew M. | Director | Water Supply | BUY | $13.50 | 111,000 | $1,498,500 | 2,066,240 | +5.7% |
| 2022-08-02 21:17 | 2022-08-01 | RILY | BRC Group Holdings, Inc. | PAULSON RANDALL E | Director | Investment Advice | BUY | $52.21 | 40,000 | $2,088,380 | 225,907 | +21.5% |
| 2022-08-02 23:27 | 2022-07-29 | ALDX | Aldeyra Therapeutics Inc. | PERCEPTIVE ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $5.03 | 222,123 | $1,117,279 | 10,245,394 | +2.2% |
| 2022-08-03 00:04 | 2022-08-01 | CYH | COMMUNITY HEALTH SYSTEMS INC | SMITH WAYNE T | Director, Officer - Executive Chairman | Services-General Medical & Surgical Hospitals, NEC | BUY | $2.95 | 1,000,000 | $2,952,000 | 4,059,196 | +32.7% |
| 2022-08-01 23:34 | 2022-07-28 | N/A | Morgan Stanley Direct Lending Fund | MS Credit Partners Holdings Inc. | 10% owner | Other | BUY | $20.45 | 482,313 | $9,863,294 | 7,851,320 | +6.5% |
| 2022-08-02 01:11 | 2022-07-29 | TXMD | TherapeuticsMD, Inc. | Rubric Capital Management LP | 10% owner | Pharmaceutical Preparations | BUY | $25.86 | 580,000 | $14,999,960 | 15,000 | +100.0% |
| 2022-08-01 23:15 | 2022-08-01 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal International S.C.A. | Director, 10% owner | Pharmaceutical Preparations | BUY | $2.50 | 16,173,800 | $40,434,500 | 48,433,261 | +50.1% |
| 2022-08-01 23:13 | 2022-08-01 | LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Pharmaceutical Preparations | BUY | $2.50 | 982,600 | $2,456,500 | 5,303,814 | +22.7% |
| 2022-08-01 23:15 | 2022-08-01 | LXRX | LEXICON PHARMACEUTICALS, INC. | Invus US Partners LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $2.50 | 982,600 | $2,456,500 | 5,303,814 | +22.7% |
| 2022-07-30 01:11 | 2022-07-27 | MKTW | MARKETWISE, INC. | Stansberry Frank Porter | 10% owner | Services-Prepackaged Software | BUY | $2.67 | 706,249 | $1,882,436 | 1,131,383 | +166.1% |
| 2022-07-29 19:10 | 2022-07-25 | N-A | N/A | FRANKLIN RESOURCES INC | 10% owner, Other | Other | BUY | $12.69 | 1,970,055 | $25,000,000 | 1,970,055 | +100.0% |
| 2022-07-29 23:00 | 2022-07-28 | MDIA | Mediaco Holding Inc. | Standard General L.P. | 10% owner | Radio Broadcasting Stations | BUY | $2.32 | 12,899,480 | $29,873,906 | 13,469,399 | +2,263.4% |
| 2022-07-29 23:06 | 2022-07-29 | BECN | N/A | CD&R Investment Associates IX, Ltd. | 10% owner | Other | BUY | $57.73 | 103,931 | $5,999,999 | 14,859,579 | +0.7% |
| 2022-07-28 19:17 | 2022-07-26 | GIM | Saba Capital Income & Opportunities Fund II | FRANKLIN RESOURCES INC | Other | Other | BUY | $4.38 | 252,120 | $1,104,714 | 1,343,117 | +23.1% |
| 2022-07-29 00:31 | 2022-07-26 | TCBI | TEXAS CAPITAL BANCSHARES INC/TX | STALLINGS ROBERT W | Director | State Commercial Banks | BUY | $55.09 | 22,000 | $1,212,020 | 4,440 | +100.0% |
| 2022-07-28 01:09 | 2022-07-27 | HCCI | N/A | Recatto Brian | Director, Officer - President & CEO | Other | BUY | $27.00 | 150,000 | $4,050,000 | 820,505 | +22.4% |
| 2022-07-27 15:30 | 2022-07-22 | PLAG | Planet Green Holdings Corp. | Zhou Bin | Director, Officer, 10% owner - Chief Executive Officer | Canned, Frozen & Preservd Fruit, Veg & Food Specialties | BUY | $1.50 | 4,800,000 | $7,200,000 | 9,062,000 | +112.6% |
| 2022-07-28 01:50 | 2022-07-25 | UAL | United Airlines Holdings, Inc. | SHAPIRO EDWARD | Director | Air Transportation, Scheduled | BUY | $35.74 | 50,000 | $1,787,020 | 150,000 | +50.0% |
| 2022-07-27 00:12 | 2022-07-22 | RVMD | Revolution Medicines, Inc. | Schroeder Thilo | Director | Biological Products, (No Diagnostic Substances) | BUY | $20.00 | 250,000 | $5,000,000 | 1,221,315 | +25.7% |
| 2022-07-26 23:28 | 2022-07-25 | CAG | CONAGRA BRANDS INC. | CHIRICO EMANUEL | Director | Food and Kindred Products | BUY | $34.06 | 30,000 | $1,021,800 | 40,788 | +278.1% |
| 2022-07-26 23:30 | 2022-07-25 | JEF | Jefferies Financial Group Inc. | JONES THOMAS W | Director | Security Brokers, Dealers & Flotation Companies | BUY | $31.21 | 40,000 | $1,248,444 | 55,962 | +250.6% |
| 2022-07-26 21:21 | 2022-07-22 | TCBI | TEXAS CAPITAL BANCSHARES INC/TX | STALLINGS ROBERT W | Director | State Commercial Banks | BUY | $54.71 | 44,430 | $2,430,712 | 2,340 | +100.0% |
| 2022-07-25 23:58 | 2022-07-22 | RVMD | Revolution Medicines, Inc. | Kim Lorence H. | Director | Biological Products, (No Diagnostic Substances) | BUY | $20.00 | 50,000 | $1,000,000 | 60,500 | +476.2% |
| 2022-07-25 15:45 | 2022-07-22 | HSAQ | Orchestra BioMed Holdings, Inc. | WONG RODERICK | Director, Officer - Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $10.01 | 1,000,000 | $10,010,000 | 1,000,000 | +100.0% |
| 2022-07-25 23:46 | 2022-07-21 | TRHC | N/A | Indaba Capital Management, L.P. | 10% owner | Other | BUY | $3.97 | 1,293,292 | $5,140,577 | 6,462,316 | +25.0% |
| 2022-07-25 23:15 | 2022-07-15 | WHLM | Wilhelmina International, Inc. | Retail Ecommerce Ventures LLC | 10% owner | Services-Management Consulting Services | BUY | $10.00 | 118,750 | $1,187,500 | 950,000 | +14.3% |
| 2022-07-23 02:25 | 2022-07-21 | AKU | N/A | SCW Capital Management, LP | 10% owner | Other | BUY | $0.52 | 3,065,257 | $1,593,934 | 3,167,742 | +2,990.9% |
| 2022-07-20 16:03 | 2022-07-18 | GIM | Saba Capital Income & Opportunities Fund II | FRANKLIN RESOURCES INC | Other | Other | BUY | $4.39 | 236,722 | $1,039,281 | 731,394 | +47.9% |
| 2022-07-21 00:17 | 2022-05-11 | SWTRX | N/A | Parfet Meredith Esther Wilson | Other | Other | BUY | $10,008.00 | 500 | $5,008,003 | 500 | +100.0% |
| 2022-07-21 04:56 | 2022-07-18 | MOND | Mondee Holdings, Inc. | Gundumogula Prasad | Director, Officer, 10% owner - Chief Executive Officer | Transportation Services | BUY | $10.00 | 100,000 | $1,000,000 | 100,000 | +100.0% |
| 2022-07-21 04:56 | 2022-07-18 | MOND | Mondee Holdings, Inc. | Fintiklis Orestes | Director | Transportation Services | BUY | $10.00 | 260,000 | $2,600,000 | 725,000 | +55.9% |
| 2022-07-20 23:02 | 2022-07-18 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner - CEO | Services-Commercial Physical & Biological Research | BUY | $145.00 | 8,330 | $1,207,850 | 5,513,639 | +0.2% |
| 2022-07-20 23:38 | 2022-07-18 | TCDA | N/A | Venrock Healthcare Capital Partners II, L.P. | 10% owner | Other | BUY | $9.18 | 150,000 | $1,377,255 | 7,464,852 | +2.1% |
| 2022-07-20 23:01 | 2022-07-18 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% owner | Services-Commercial Physical & Biological Research | BUY | $145.00 | 8,330 | $1,207,850 | 5,513,639 | +0.2% |
| 2022-07-19 19:41 | 2022-07-15 | N-A | N/A | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $15.71 | 381,202 | $5,989,947 | 6,983,967 | +5.8% |
| 2022-07-19 19:25 | 2022-07-15 | N-A | N/A | Manulife (International) Ltd | 10% owner | Other | BUY | $15.71 | 827,326 | $13,000,023 | 5,332,696 | +18.4% |
| 2022-07-19 19:13 | 2022-07-15 | N-A | N/A | Manufacturers Life Insurance Co (Bermuda Branch) | 10% owner | Other | BUY | $15.71 | 1,018,248 | $16,000,029 | 3,526,490 | +40.6% |
| 2022-07-19 21:49 | 2022-07-18 | OXY | OCCIDENTAL PETROLEUM CORP /DE/ | BERKSHIRE HATHAWAY INC | 10% owner | Crude Petroleum & Natural Gas | BUY | $59.67 | 242,241 | $14,455,320 | 181,684,791 | +0.1% |
| 2022-07-18 23:06 | 2022-07-14 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner - CEO | Services-Commercial Physical & Biological Research | BUY | $144.59 | 22,290 | $3,222,911 | 5,505,309 | +0.4% |
| 2022-07-18 23:04 | 2022-07-14 | MEDP | Medpace Holdings, Inc. | Medpace Investors, LLC | 10% owner | Services-Commercial Physical & Biological Research | BUY | $144.59 | 22,290 | $3,222,911 | 5,505,309 | +0.4% |
| 2022-07-19 00:00 | 2022-07-14 | ET | Energy Transfer LP | Brannon Richard D | Director | Natural Gas Transmission | BUY | $9.69 | 137,680 | $1,334,656 | 500,000 | +38.0% |
| 2022-07-18 19:48 | 2022-07-14 | EPIX | N/A | BIOTECH GROWTH N V | 10% owner | Other | BUY | $2.93 | 588,869 | $1,726,211 | 5,579,583 | +11.8% |
| 2022-07-19 00:32 | 2022-07-14 | OXY | OCCIDENTAL PETROLEUM CORP /DE/ | BERKSHIRE HATHAWAY INC | 10% owner | Crude Petroleum & Natural Gas | BUY | $57.70 | 1,942,900 | $112,113,296 | 181,684,791 | +1.1% |
| 2022-07-15 00:17 | 2022-07-12 | GIM | Saba Capital Income & Opportunities Fund II | Saba Capital Management, L.P. | 10% owner | Other | BUY | $4.40 | 1,287,565 | $5,669,149 | 31,847,742 | +4.2% |
| 2022-07-15 04:01 | 2022-07-13 | SONM | DNA X, Inc. | Wang Jeffrey | Director, 10% owner | Telephone & Telegraph Apparatus | BUY | $0.84 | 13,928,571 | $11,700,000 | 13,928,571 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.